New York State Department of Health
Sema4's GeneDx to Provide Genome Sequencing, Interpretation for Large-Scale Newborn Screening Study
The GUARDIAN (Genomic Uniform-screening Against Rare Diseases in All Newborns) study plans to screen 100,000 newborns for up to 250 rare genetic conditions.
DxTerity Gets New York State Authorization for Systemic Lupus Erythematosus Test
The test is used to identify patients less likely to respond to standard treatment and more likely to develop a severe kidney disorder.
New York State Approves Enzo Biochem HPV Molecular Test
Enzo expects to make several announcements related to other molecular laboratory-developed tests this year and provide a timeline for US FDA submissions.
Applied DNA Sciences Gets Conditional NY State Approval for COVID-19 Test
Applied DNA said that it now intends to submit the test for Emergency Use Authorization from the US Food and Drug Administration.
Phosphorus Wins Conditional New York State Approval for GeneCompass Consumer Test
The firm's health screening sequencing assay, which retails at $249 and covers a panel of over 400 genes, will now be available to consumers in all 50 states.
Feb 24, 2020